Is Quick Heal Technologies profitable in 2026?

No. Quick Heal posted a full-year net loss in FY26 (ended March 31, 2026), erasing nearly ₹100 crore of annual profit it used to generate. Q4 FY26 alone saw revenue fall 25.19% YoY to ₹48.73 crore with a net loss of ₹19.94 crore, which management called the worst quarter in company history.

Could AI replace Quick Heal's antivirus business?

Quick Heal's legacy signature-based consumer antivirus is highly exposed since Windows Defender ships free with Windows and AI-native global tools commoditize detection. This shows up in results: consumer revenue has posted double-digit declines through FY26. Enterprise Seqrite products use proprietary AI (GoDeep.AI) but haven't yet stabilized overall financials.

Who is Quick Heal Technologies' biggest competitor?

On the consumer side, Windows Defender (free, OS-bundled) is the structural threat causing revenue decline. On enterprise, global EDR/XDR vendors CrowdStrike, SentinelOne, Bitdefender, Fortinet, and Check Point already sell into India and are not structurally blocked, only slower to prioritize the market as of mid-2026.

Who owns Quick Heal Technologies?

Quick Heal is publicly listed on NSE and BSE since its February 2016 IPO, remaining promoter-controlled by the Katkar family (founders Kailash and Sanjay Katkar). In June 2025, promoter Sneha Kailash Katkar acquired a 6.14% stake via an intra-family inter-se transfer, described as succession planning, not new capital.

Why did Quick Heal Technologies stock crash in 2026?

Quick Heal's stock fell from a 52-week high of ₹371 to as low as ₹125 by mid-2026 (all-time high was ₹825.9) as revenue deteriorated: Q4 FY26 revenue dropped 25.19% YoY to ₹48.73 crore and the net loss widened to ₹19.94 crore, driven by consumer antivirus decline against free competitors like Windows Defender.

Can Quick Heal's Seqrite enterprise business save the company?

Seqrite enterprise revenue reportedly exceeds 50% of total revenue per Q4 FY26 commentary, versus about 43% per a June 2026 report, and the company won a ₹64.25 crore NFSU-RIC contract. Management said the consumer-to-enterprise transition could take up to two more quarters as of the May 2026 earnings call.

Cybersecurity companies · India

Quick Heal Technologies

quickheal.com ↗

Indian antivirus maker selling consumer AV plus Seqrite enterprise security software.

Losing its protection

Assessed 26 July 2026 · Evidence as of 26 July 2026

The structural protection is eroding.

On the recordSince 26 July 2026 · Checkable from August 2026 · Every call on the record Checkpoint: Q1 FY27 results, first full quarter under new CEO Harish Kumar GS

The call

Consumer antivirus revenue is shrinking fast while Seqrite enterprise grows toward half of sales, leaving the turnaround riding on a new CEO with no track record yet.

Quick Heal makes antivirus and cybersecurity software sold in India. Its consumer antivirus business is being crushed by free built-in protection from Windows and by cheaper AI-powered rivals, making it nearly impossible to charge customers for what used to be a paid product. The company is betting its survival on Seqrite, its enterprise security division, becoming profitable and growing past 55 percent of sales, but global competitors like CrowdStrike and SentinelOne are already moving into India and face no real barriers to taking that business away. The one thing that could help: if India's new data protection law (DPDP Act) becomes strictly enforced and favors local companies, it might slow down foreign competitors enough to give Quick Heal's enterprise business time to prove it can make money.

Why

AI pressure: Microsoft Defender, free AI-native bundled protection on Windows. Consumer antivirus revenue keeps falling double digits as free, AI-driven Windows Defender covers what people used to pay Quick Heal for. Could AI do the core job? Yes, likely.

Bigger players: CrowdStrike, SentinelOne, Bitdefender, Fortinet, Check Point. These global EDR vendors already sell in India; only certification and procurement rules currently keep them out of Seqrite's government and BFSI accounts. Could a giant copy it? Yes, easily.

What protects it. India's DPDP Act, government certification requirements, and a 33,000-partner distribution network slow foreign EDR vendors from taking Seqrite's enterprise accounts.

What would change this call

Quick Heal's Q1 FY27 and Q2 FY27 results show Seqrite revenue mix crossing 55-60% with margin recovery. Would show the enterprise pivot is succeeding and offsetting consumer erosion.
Consumer antivirus revenue decline narrows from ~25% YoY to single digits in coming quarters. Would show the core consumer business stabilizing rather than continuing structural collapse.
CrowdStrike, SentinelOne, or Bitdefender announce Indian government or DPDP Act certification. Would show Seqrite's last protected niche (regulatory/procurement bar) is breached by global rivals.

Key numbers

Q4 FY26 net loss widened to Rs 19.94 crore, revenue down 25% YoY (2026-03-31)
FY26 full-year revenue Rs 261.0 crore, down 6.6% YoY (2026-03-31)
Cash and investments Rs 249 crore as of May 2026 (2026-05-29)

Named risks

Consumer antivirus revenue collapse against free bundled alternatives with no structural defense. Severity: high
Two CEO changes within 12 months during a critical enterprise pivot, with new CEO having zero quarters of track record as of June 2026. Severity: high
Global EDR vendors could win Indian government or DPDP certification, eroding the last defensible enterprise segment. Severity: medium
Consolidated net loss and cash decline from ₹249 crore risk accelerating burn if turnaround stalls. Severity: medium
Hiring freeze in non-core functions could slow product development velocity during a critical transition. Severity: low

Rivals, as read in July 2026

Rival	Direction	Evidence
Microsoft Defender	losing to	Free OS-bundled protection drives consumer antivirus double-digit revenue declines through FY26
CrowdStrike	contesting	Already sells into India through integrators as of December 2025, not yet certified for Indian government procurement
SentinelOne	contesting	Operates in Indian enterprise EDR market as of 2026, no government certification breakthrough confirmed yet
Bitdefender	contesting	Cited as category-adjacent competitor to Seqrite enterprise products in 2026 comparison listings
Check Point Software	contesting	New Quick Heal CEO Harish Kumar GS previously led Check Point India and SAARC sales as of June 2026

Questions people ask

Is Quick Heal Technologies profitable in 2026?: No. Quick Heal posted a full-year net loss in FY26 (ended March 31, 2026), erasing nearly ₹100 crore of annual profit it used to generate. Q4 FY26 alone saw revenue fall 25.19% YoY to ₹48.73 crore with a net loss of ₹19.94 crore, which management called the worst quarter in company history.
Could AI replace Quick Heal's antivirus business?: Quick Heal's legacy signature-based consumer antivirus is highly exposed since Windows Defender ships free with Windows and AI-native global tools commoditize detection. This shows up in results: consumer revenue has posted double-digit declines through FY26. Enterprise Seqrite products use proprietary AI (GoDeep.AI) but haven't yet stabilized overall financials.
Who is Quick Heal Technologies' biggest competitor?: On the consumer side, Windows Defender (free, OS-bundled) is the structural threat causing revenue decline. On enterprise, global EDR/XDR vendors CrowdStrike, SentinelOne, Bitdefender, Fortinet, and Check Point already sell into India and are not structurally blocked, only slower to prioritize the market as of mid-2026.
Who owns Quick Heal Technologies?: Quick Heal is publicly listed on NSE and BSE since its February 2016 IPO, remaining promoter-controlled by the Katkar family (founders Kailash and Sanjay Katkar). In June 2025, promoter Sneha Kailash Katkar acquired a 6.14% stake via an intra-family inter-se transfer, described as succession planning, not new capital.
Why did Quick Heal Technologies stock crash in 2026?: Quick Heal's stock fell from a 52-week high of ₹371 to as low as ₹125 by mid-2026 (all-time high was ₹825.9) as revenue deteriorated: Q4 FY26 revenue dropped 25.19% YoY to ₹48.73 crore and the net loss widened to ₹19.94 crore, driven by consumer antivirus decline against free competitors like Windows Defender.
Can Quick Heal's Seqrite enterprise business save the company?: Seqrite enterprise revenue reportedly exceeds 50% of total revenue per Q4 FY26 commentary, versus about 43% per a June 2026 report, and the company won a ₹64.25 crore NFSU-RIC contract. Management said the consumer-to-enterprise transition could take up to two more quarters as of the May 2026 earnings call.

Timeline

2026-06-18Harish Kumar GS, ex-Check Point India sales head, appointed CEO to lead enterprise pivot
2026-05-29Q4 FY26 results called worst quarter in company history on earnings call
2026-05-21Q4 FY26 net loss widens to ₹19.94 crore, revenue down 25.19% YoY to ₹48.73 crore
2026-03-31FY26 ends with consolidated revenue ₹261.0 crore, down 6.6% YoY, full-year net loss
2026-02-01Hiring freeze announced in non-core functions amid cost pressure
2025-10-16Q2 FY26 revenue rebounds 46% sequentially to ₹83.5 crore, PAT ₹7.9 crore
2025-07-09CEO Vishal Salvi resigns, effective August 31, 2025
2025-06-19Promoter Sneha Kailash Katkar acquires 6.14% stake via intra-family transfer
2016-02-08Quick Heal IPO priced at ₹311 to ₹321 per share, raising ₹250 crore

Revision history

26 July 2026

First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.

In the same band

Seqrite Meiya Pico NSFOCUS